Skip to main content

Table 5 Responsiveness of measures over time to self-reported hand and wrist functioning; baseline to 4 months

From: An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand

  n T0 T4 Δ (95% CI) SRM (95% CI) ES (95% CI)
MHQ
 Improved 177 51.66 64.79 13.13 (9.67 to 16.58) 0.56 (-1.88 to 3.00) 0.79 (-1.64 to 3.23)
 No change 150 54.15 56.97 2.82 (-0.96 to 6.59) 0.12 (-2.55 to 2.79) 0.16 (-2.51 to 2.83)
 Worsened 113 47.2 45.37 -1.83 (-6.03 to 2.36) -0.08 (-3.05 to 2.89) -0.11 (-3.08 to 2.85)
EQ-5D (utility)
 Improved 177 0.58 0.69 0.11 (0.06 to 0.16) 0.31 (0.27 to 0.36) 0.44 (0.41 to 0.49)
 No change 150 0.61 0.62 0.01 (-0.04 to 0.06) 0.03 (-0.01 to 0.07) 0.04 (0.00 to 0.08)
 Worsened 113 0.55 0.48 -0.07 (-0.15 to 0.01) -0.16 (-0.22 to -0.11) -0.23 (-0.28 to -0.18)
EQ-5D (VAS)
 Improved 177 68.28 75.78 7.5 (3.9 to 11.10) 0.31 (-2.38 to 3.00) 0.43 (-2.26 to 3.13)
 No change 150 68.99 67.46 -1.53 (-5.67 to 2.62) -0.05 (-2.87 to 2.76) -0.08 (-2.90 to 2.73)
 Worsened 113 64.92 60.43 -4.49 (-9.50 to 0.52) -0.16 (-3.81 to 3.48) -0.23 (-3.88 to 3.41)
SF-12 (PCS)
 Improved 177 34.59 36.63 2.04 (-0.5 to 4.58) 0.12 (-1.44 to 1.67) 0.19 (-1.71 to 2.11)
 No change 150 33.13 34.48 1.35 (-1.31 to 4.01) 0.081 (-1.89 to 2.05) 0.11 (-1.85 to 2.08)
 Worsened 113 31.43 30.44 -0.99 (-3.83 to 1.86) -0.06 (-2.04 to 1.91) -0.09 (-2.06 to 1.88)
SF-12 (MCS)
 Improved 177 48.98 48.12 -0.86 (-3.69 to 1.98) -0.04 (-1.75 to 1.66) -0.06 (-1.77 to 1.65)
 No change 150 46.52 49.29 2.77 (-0.44 to 5.98) 0.13 (-2.34 to 2.62) 0.19 (-2.29 to 2.68)
 Worsened 113 46.02 44.01 -2.01 (-5.76 to 1.74) -0.09 (-2.75 to 2.55) -0.14 (-2.79 to 2.51)
SF-6D
 Improved 177 0.65 0.68 0.03 (-0.00 to 0.06) 0.15 (0.12 to 0.16) 0.21 (0.19 to 0.23)
 No change 150 0.65 0.65 0 (-0.03 to 0.03) 0 (-0.02 to 0.02) 0 (-0.02 to 0.02)
 Worsened 113 0.6 0.59 -0.01 (-0.05 to 0.03) -0.05 (-0.07 to -0.02) -0.07 (-0.09 to -0.04)